Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
J Child Neurol ; 34(7): 367-370, 2019 06.
Article in English | MEDLINE | ID: mdl-30782060

ABSTRACT

INTRODUCTION: Since its creation, patients on ketogenic diet are told to avoid liquid medications due to theoretical concerns of "hidden" carbohydrates. However, switching from liquid to tablet formulations can be problematic, especially for infants and young children. We theorized that increasing the daily ketogenic ratio might compensate for liquid antiseizure drug carbohydrates. METHODS: Two tables were created (for 3:1 and 4:1 ketogenic ratios), with variables including daily volume of antiseizure drugs and calories. Cases were those who had their ratio increased and liquid medications continued. Children already on tablet formulations, emergency situations, were primarily those included as controls. RESULTS: From May 2016 through August 2018, 59 children (33 cases and 26 controls) ages 0.3-14 years were started on the classic ketogenic diet. Compensated antiseizure drugs most commonly included levetiracetam, clobazam, and valproate (mean volume 16 mL/d (range: 3-62 mL/d)). Adjusted ratios for younger children and infants on a 3:1 diet ranged from 3.1 to 3.5:1 and older children on a 4:1 diet from 4.2 to 4.7:1. There was no difference between cases and controls in achieving large ketosis (76% vs 77%), weight gain (1.4 vs 1.2 kg), 1 month >50% seizure reduction (52% vs 50%), or >90% seizure reduction (30% vs 35%). Four (12%) cases had zero or small urinary ketosis, which improved when antiseizure drugs were switched to tablets or discontinued. CONCLUSIONS: This proof-of-principle study demonstrates feasibility of compensating for carbohydrates in liquid medications by increases in the daily ketogenic ratio. This ratio adjustment protocol may help ease an already complex adjustment to dietary therapy.


Subject(s)
Anticonvulsants/therapeutic use , Diet, Ketogenic/methods , Epilepsy/therapy , Ketosis , Seizures/therapy , Adolescent , Anticonvulsants/administration & dosage , Anticonvulsants/chemistry , Carbohydrates , Case-Control Studies , Child , Child, Preschool , Epilepsy/diet therapy , Epilepsy/drug therapy , Female , Humans , Infant , Male , Seizures/diet therapy , Seizures/drug therapy , Treatment Outcome
2.
J Child Neurol ; 33(4): 290-296, 2018 03.
Article in English | MEDLINE | ID: mdl-29433418

ABSTRACT

Fine-tuning ketogenic diets to achieve better seizure control may influence families to seek second opinions. Since 2009, Johns Hopkins Hospital has provided second opinions for children followed at other ketogenic diet centers. We retrospectively reviewed 65 consecutive children seen in this clinic; parents were also sent a 2-page survey. The mean age was 6.6 years and dietary therapy had been used a median 9 months. Seizure reduction >50% was achieved in 65%, including 35% with >90% reduction. Parent questions included how to improve seizure control (65%), ideal diet duration (18%), and confirmation of the plan (11%). The most common recommendations were anticonvulsant reduction (43%), adding oral citrates/calcium/vitamins (38%), and carnitine supplementation (31%). Diet discontinuation was more frequently suggested in those children with <50% seizure reduction (60% vs 20%, P = .001). Recommendations were successful in 78%, and the visit was reported as useful by 88%.


Subject(s)
Diet, Ketogenic , Seizures/diet therapy , Adolescent , Anticonvulsants/adverse effects , Anticonvulsants/therapeutic use , Child , Child, Preschool , Diet, Ketogenic/adverse effects , Female , Follow-Up Studies , Humans , Infant , Male , Parents/psychology , Referral and Consultation , Retrospective Studies , Seizures/drug therapy , Treatment Outcome
3.
J Child Neurol ; 32(9): 828-833, 2017 08.
Article in English | MEDLINE | ID: mdl-28482736

ABSTRACT

Traditionally the ketogenic diet is started as an inpatient admission to the hospital. Starting in January 2015, child life services were made formally available during ketogenic diet admissions to help families cope. One-page surveys were then provided to 15 parents on the day of discharge and again after 3 months. Every family believed that the child life services were helpful. Children who were developmentally appropriate/mildly delayed had higher parent-reported anxiety scores than those who were moderate to severely delayed (4.4 vs 1.0, P = .02). At 3 months, child life services were deemed very helpful for the parents (mean score: 8.9, range: 5-10), and were more helpful for the parent than the child (mean 6.2, range 1-10, P = .047). One of the most helpful services was a prior phone call to parents 1 week prior. In this small pilot study, child life involvement during the start of the ketogenic diet was highly useful.


Subject(s)
Child Health Services , Diet, Ketogenic , Drug Resistant Epilepsy/diet therapy , Drug Resistant Epilepsy/psychology , Hospitalization , Parents/psychology , Adaptation, Psychological , Adolescent , Allied Health Personnel , Anxiety , Child , Child, Preschool , Diet, Ketogenic/psychology , Follow-Up Studies , Humans , Infant , Patient Education as Topic , Pilot Projects , Professional-Patient Relations , Quality of Life , Surveys and Questionnaires , Telephone
4.
Epilepsy Behav ; 29(3): 437-42, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24386671

ABSTRACT

The modified Atkins diet has been used since 2003 for the treatment of children and adults with refractory epilepsy.This "alternative" ketogenic diet is started in clinic, without fasting, hospitalization, and restriction of protein,calories, or fluid intake. Now after 10 years of continued use, approximately 400 patients have been reported in over 30 studies of the modified Atkins diet as treatment for intractable seizures, with results demonstrating similar efficacy to the ketogenic diet and improved tolerability. The modified Atkins diet is being increasingly used in the adult population. Clinical trials have provided insight into the mechanisms of action of dietary therapies overall. This review will discuss the past decade of experience with the modified Atkins diet as well as predictions for its role in the treatment of epilepsy a decade from now.


Subject(s)
Diet, Carbohydrate-Restricted/standards , Diet, Carbohydrate-Restricted/trends , Diet, Carbohydrate-Restricted/history , Epilepsy/therapy , History, 20th Century , History, 21st Century , Humans
SELECTION OF CITATIONS
SEARCH DETAIL